Preferences help
enabled [disable] Abstract
Number of results
2004 | 51 | 2 | 445-457
Article title

The role of cell adhesion molecule in cancer progression and its application in cancer therapy.

Title variants
Languages of publication
Multiple and diverse cell adhesion molecules take part in intercellular and cell-extracellular matrix interactions of cancer. Cancer progression is a multi-step process in which some adhesion molecules play a pivotal role in the development of recurrent, invasive, and distant metastasis. A growing body of evidence indicates that alterations in the adhesion properties of neoplastic cells play a pivotal role in the development and progression of cancer. Loss of intercellular adhesion and the desquamation of cells from the underlying lamina propria allows malignant cells to escape from their site of origin, degrade the extracellular matrix, acquire a more motile and invasion phenotype, and finally, invade and metastasize. In addition to participating in tumor invasiveness and metastasis, adhesion molecules regulate or significantly contribute to a variety of functions including signal transduction, cell growth, differentiation, site-specific gene expression, morphogenesis, immunologic function, cell motility, wound healing, and inflammation. Cell adhesion molecule (CAM), a diverse system of transmembrane glycoproteins has been identified that mediates the cell-cell and cell-extracellular matrix adhesion and also serves as the receptor for different kinds of virus. We summarize recent progress regarding the role of CAM, particularly, immunoglobulin-CAMs and cadherins in the progression of cancer and discuss the potential application of CAMs in the development of cancer therapy mainly on urogenital cancer.
Physical description
  • Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A.
  • Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A.
  • Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A.
  • Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas, U.S.A.
  • Arenas MI, Romo E, Royuela M, Fraile B, Paniagua R. (2000) E-, N- and P-cadherin and α-, β-, and γ-catenin protein expression in normal, hyperplastic and carcinomatous human prostate. Histochem J.; 32: 659-67.
  • Banks RE, Porter WH, Whelan P, Smith PH, Selby PJ. (1995) Soluble forms of the adhesion molecule E-cadherin in urine. J Clin Pathol.; 48: 179-80.
  • Behrens J, Mareel MM, Van Roy FM, Birchmeier W. (1989) Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol.; 108: 2435-47.
  • Bergelson JM, Cunningham JA, Drouguett G, Kurt-Joned EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science.; 275: 1320-3.
  • Birchmeier W, Behrens J. (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta.; 1198: 11-26.
  • Bonkhoff H, Remberger K. (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate.; 28: 98-106.
  • Brewster SF, Gingell JC, Browne S, Brown KW. (1994) Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer.; 70: 697-700.
  • Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA. (1992) Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res.; 52: 2916-22.
  • Cavallaro U, Christofori G. (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer.; 4: 118-32.
  • Chen YQ, Hsieh JT, Yao F, Fang B, Pong RC, Cipriano SC, Krepulat F. (1999) Induction of apoptosis and G2/M cell cycle arrest by DCC. Oncogene.; 18: 2747-54.
  • Cheng L, Nagabhushan M, Pretlow TP, Amini SB, Pretlow TG. (1996) Expression of E-cadherin in primary and metastatic prostate cancer. Am J Pathol.; 148: 1375-80.
  • Cho KR, Fearon ER. (1995) DCC: linking tumor suppressor genes and altered cell surface interactions in cancer? Curr Opin Genet Dev.; 5: 72-8.
  • Coffey DS, Walsh PC. (1990) Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am.; 17: 461-75.
  • Cohen MB, Grieblin TL, Ahaghotu CA, Rokhlin OW, Ross JS. (1997) Cellular adhesion molecules in urologic malignancies. Am J Clin Path.; 107: 56.
  • Cohen CJ, Pickles RJ, Okegawa T, Hsieh JT, Bergelson J. (2001) The coxsackie virus and adenovirus receptor (CAR) is a transmembrane component of the tight junction. Proc Natl Acad Sci USA.; 98: 15191-96.
  • Daniel JM, Reynolds AB. (1997) Tyrosine phosphorylation and cadherin/catenin function. Bioessays.; 19: 883-91.
  • Daniel CW, Strickland P, Friedmann Y. (1995) Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Develop Biol.; 169: 511-9.
  • Estrera VT, Chen DT, Luo W, Hixson DC, Lin SH. (2001) Signal transduction by the CEACAM1: phosphorylation of serine 503 is required for growth-inhibitory activity. J Biol Chem.; 276: 15547-53.
  • Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB. (1995) Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. Cancer Res.; 55: 4813-7.
  • Fazeli A, Dickinson SL, Hermiston ML, Tighe RV, Steen RG, Small CG, Stoeckli ET, Keino-Masu K, Masu M, Rayburn H, Simons J, Bronson RT, Gordon JI, Tessier-Lavigne M, Weinberg RA. (1997) Phenotype of mice lacking functional deleted in colorectal cancer (DCC) gene. Nature.; 386: 796-804.
  • Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW. (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science.; 247: 49-56.
  • Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol.; 113: 173-85.
  • Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB. (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res.; 55: 5195-9.
  • Griffiths TR, Brotherick I, Bishop RI, White MD, McKenna DM, Horne CH, Shenton BK, Neal DE, Mellon JK. (1996) Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer.; 74: 579-84.
  • Hatta K, Takagi S, Fujisawa H, Takeichi M. (1987) Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Develop Biol.; 120: 215-27.
  • Hazan RB, Kang L, Whooley BP, Borgen PI. (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun.; 4: 399-411.
  • Hedrick L, Cho K, Vogelein B. (1993) Cell adhesion as tumor suppressors. Trends Cell Biol.; 3: 36-9.
  • Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, Vogelstein B. (1994) The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Develop.; 8: 1174-83.
  • Hemmi S, Geertsen R, Mezzacasa A, Peter I, Dummer R. (1998) The presence of human coxsackie virus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther.; 9: 2363-73.
  • Hemminki A, Kanerva A, Liu B, Wang M, Alvarez RD, Siegal GP, Curiel DT. (2003) Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res.; 63: 847-53.
  • Hirai Y, Nose A, Kobayashi S, Takeichi M. (1989) Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis. Development.; 105: 271-7.
  • Hixson DC, McEntire KD, Obrink B. (1985) Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas. Cancer Res.; 45: 3742-9.
  • Hsieh JT, Lin SH. (1994) Androgen regulation of cell adhesion molecule gene expression in rat prostate during organ degeneration. C-CAM belongs to a class of androgen-repressed genes associated with enriched stem/amplifying cell population after prolonged castration. J Biol Chem.; 269: 3711-16.
  • Hsieh JT, Luo W, Song W, Wang Y, Kleinerman DI, Van NT, Lin SH. (1995) Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res.; 55: 190-7.
  • Hsieh JT, Earley K, Pong RC, Wang Y, Van NT, Lin SH. (1999) Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer. Prostate.; 41: 31-8.
  • Jarrard DF, Paul R, van Bokhoven A, Nguyen SH, Bova GS, Wheelock MJ, Johnson KR, Schalken J, Bussemakers M, Isaacs WB. (1997) P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. Clin Cancer Res.; 3: 2121-8.
  • Jou TS, Stewart DB, Stappert J, Nelson WJ, Marrs JA. (1995) Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA.; 92: 5067-71.
  • Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I. (1994) Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer.; 69: 580-5.
  • Kitazono M, Goldsmith ME, Aikou T, Bates S, Fojo T. (2001) Enhanced adenovirus transgene in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res.; 61: 6328-30.
  • Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. (1995a) Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res.; 55: 1215-20.
  • Kleinerman D, Zhang WW, von Eschenbac AC, Lin SH, Hsieh JT. (1995b) Application of a tumor suppressor gene, C-CAM1, in androgen-independent prostate cancer therapy: a preclinical study. Cancer Res.; 55: 2831-6.
  • Kleinerman D, Diney C, Zhang WW, Lin S-H, Van NT, Hsieh JT. (1996) Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res.; 56: 3431-5.
  • Kolodziej PA, Timpe LC, Mitchell KJ, Fried SR, Goodman CS, Jan LY, Jan YN. (1996) frazzled encodes a Drosophila member of the DCC immunoglobulin subfamily and is required for CNS and motor axon guidance. Cell.; 87: 197-204.
  • Kovacs EM, Ali RG, McCormack AJ, Yap AS. (2002) E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts. J Biol Chem.; 277: 6708-18.
  • Lee C, Seol JY, Park K, Yoo C, Kim YW, Ahn C, Song Y, Han SK, Han JS, Kin S, Lee J, Shim Y. (2001) Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate. Clin Cancer Res.; 7: 210-4.
  • Li D, Duan L, Freimuth P, O'Malley W Jr. (1999a) Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin Cancer Res.; 5: 4175-81.
  • Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, Wang Z, Hsieh JT. (1999b) Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res.; 59: 325-30.
  • Lin SH, Guidotti G. (1989) Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. J Biol Chem.; 264: 14408-14.
  • Lucas A, Kremer EJ, Hemmi S, Luis J, Vignon F, Lazennec G. (2003) Comparative transductions of breast cancer cells by three DNA viruses. Biochem Biophys Res Commun.; 309: 1011-6.
  • Luo W, Earley K, Tantingco V, Hixson DC, Liang TC, Lin SH. (1998) Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition. Oncogene.; 16: 1141-7.
  • Malkowicz SB, Tomaszewski JE, Linnebach AJ, Cangiano TA, Maruta Y, McGarvey TW. (1996) Novel p21WAF1/CIP1 mutations in superficial and invasive transitional carcinomas cell. Oncogene.; 13: 1831-7.
  • Marshall JL, Rizvi N, Kauh J, Dahut W, Figuera M, Kang MH, Figg WD, Wainer I, Chaissang C, Li MZ, Hawkins MJ. (2002) A phase I trial of depsipeptide (FR901228) in patients with advanced cancer. J Exp Ther Oncol.; 2: 325-32.
  • McPherson JD, Morton RA, Ewing CM, Wasmuth JJ, Overhauser J, Nagafuchi A, Tsukita S, Isaacs WB. (1994) Assignment of the human α-catenin gene (CTNNA1) to chromosome 5q21-q22. Genomics.; 19: 188-90.
  • Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D, Curiel DT. (1998) Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res.; 58: 5738-48.
  • Miyamoto H, Shuin T, Ikeda I, Hosaka M, Kubota Y. (1996) Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer. J Urol.; 155: 1444-7.
  • Morita N, Uemura H, Tsumatani K, Cho M, Hirao Y, Okajima E, Konishi N, Hiasa Y. (1999) E-cadherin and α-, β- and γ-catenin expression in prostate cancers: correlation with tumour invasion. Br J Cancer.; 79: 1879-83.
  • Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. (1993) Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res.; 53: 3585-90.
  • Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C. (1993) Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA.; 90: 10744-8.
  • Noren NK, Arthur WT, Burridge K. (2003) Cadherin engagement inhibits RhoA via p190RhoGAP. J Biol Chem.; 278: 13615-8.
  • Ocklind C, Obrink B. (1982) Intercellular adhesion of rat hepatocytes. Identification of a cell surface glycoprotein involved in the initial adhesion process. J Biol Chem.; 257: 6788-95.
  • Okegawa T, Li Y, Pong RC, Zhou J, Bergelson JM, Hsieh JT. (2000) The impact of coxsackie and adenovirus receptor on human prostate cancer gene therapy. Cancer Res.; 60: 5031-6.
  • Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT. (2001) The mechanism of growth inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of CAR protein structure. Cancer Res.; 61: 6592-600.
  • Ozawa M, Baribault H, Kemler R. (1989) The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J.; 8: 1711-7.
  • Peralta Soler A, Knudsen KA, Jaurand MC, Johnson KR, Wheelock MJ, Klein-Szanto AJ, Salazar H. (1995) The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum Pathol.; 26: 1363-9.
  • Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H. (1997) Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol.; 28: 734-9.
  • Pu YS, Luo W, Lu HH, Greenberg NM, Lin SH, Gingrich JR. (1996) Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model. J Urol.; 162: 892-6.
  • Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD, McCormick F. (2002) Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res.; 62: 3812-8.
  • Rosenberg M, Nedellec P, Jothy S, Fleiszer D, Turbide C, Beauchemin N. (1993) The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues. Cancer Res.; 53: 4938-45.
  • Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ, Schoenberg MP, Rodriguez R. (2002) Integrin α(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology.; 60: 531-6.
  • Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, Debruyne FM, Bringuier PP. (1996) Prognostic value of cadherin-associated molecules (α-, β-, and γ-catenins and p120cas) in bladder tumors. Cancer Res.; 56: 4154-8.
  • Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M, Abe O. (1989) Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res.; 49: 2128-3.
  • Soler AP. Harner GD. Knudsen KA. McBrearty FX. Grujic E. Salazar H. Han AC. Keshgegian AA. (1997) Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology. Am J Pathol.; 151: 471-8.
  • Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW. (1994) Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res.; 54: 3544-52.
  • Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J. (1996) Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer.; 17: 225-33.
  • Taddei I, Piazzini M, Bartoletti R, Dal Canto M, Sardi I. (2000) Molecular alterations of E-cadherin gene: possible role in human bladder carcinogenesis. Int J Mol Med.; 6: 201-8.
  • Takeichi M. (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science.; 251: 1451-5.
  • Tomko RP, Xu R, Philipson L. (1997) HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA.; 94: 3352-6.
  • van Raaij MJ, Chouin E, van der Zandt H, Bergelson JM, Cusack S. (2000) Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 Å resolution. Structure Fold Des.; 8: 1147-55.
  • Volpert O, Luo W, Liu TJ, Estrera VT, Logothetis C, Lin SH. (2002) Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J Biol Chem.; 277: 35696-702.
  • Wong AS, Gumbiner BM. (2003) Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol.; 161: 1191-203.
  • Zabner J, Cheng SH, Meeker D, Meeker D, Launspach J, Balfour R, Perricone MA, Morris JE, Marshall J, Fasbender A, Smith AE, Welsh MJ. (1997) Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J Clin Invest.; 100: 1144-9.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.